PDCD1 and cancer: In this regard, we demonstrated that patients with better response to anti-PD-1/PD-L1 were mostly associated with low proportion of DP Temra cells, thus providing a potential use of DP pTemra as a predictive biomarker to diagnose patients with various types of cancer.